Faruqi & Faruqi, LLP Launches Major Investigation Into agilon health, inc. (NYSE: AGL)

New York, January 22, 2026 — Faruqi & Faruqi, LLP, a nationally recognized securities law firm, has publicly announced a comprehensive legal investigation on behalf of shareholders of agilon health, inc. (NYSE: AGL), alleging potential violations of federal securities laws related to false and misleading statements by the Company and its leadership. This announcement also serves as a formal reminder for agilon health investors to act before the upcoming March 2, 2026 deadline to seek the role of lead plaintiff in the class action lawsuit that has been filed.

Background: Who Is Faruqi & Faruqi, LLP?

Faruqi & Faruqi is a well-established national securities litigation law firm with offices in New York, Pennsylvania, California, and Georgia. Since its founding in 1995, the firm has represented numerous investors and recovered significant financial remedies on behalf of securities class members. Their involvement in high-profile shareholder litigation has made them a leading advocate for investors asserting their rights against corporate misconduct.

What Is the agilon health Lawsuit About?

The complaint central to this investigation alleges that agilon health and certain of its executives made false or misleading public statements and failed to disclose material facts to investors during a specific period of time, spanning from February 26, 2025 through August 4, 2025. These alleged misrepresentations and omissions reportedly concerned key aspects of the Company’s business operations, financial guidance, and the impacts of industry headwinds that were already affecting performance.

Key Allegations Listed in the Legal Claim

• The Company issued overly optimistic financial forecasts for 2025, despite internal knowledge of industry pressures and challenges that made those targets unlikely to be achieved.
• agilon health allegedly overstated the positive effects of strategic actions it took to mitigate risk, suggesting outcomes that were not supported by underlying results.
• Investors were not informed of material developments related to costs and utilization trends that significantly impacted the Company’s operations, undermining transparency.

According to the allegations, these actions and statements created an inaccurate picture of agilon’s financial health and future prospects. Once the truth became public, investors suffered substantial losses.

Market Impact: Stock Decline and Investor Losses

One of the most significant market reactions tied to the underlying allegations occurred following the release of the Company’s Second Quarter 2025 financial results on August 4, 2025. In that announcement, agilon health surprised the market by suspending its previously issued full-year 2025 guidance due to more severe industry headwinds than expected. Analysts and investors reacted negatively, and the Company’s stock price plummeted by approximately 51.5 % the very next day. This sudden and steep decline is central to claims that shareholders suffered financial damages because of previously undisclosed or misstated information.

Lead Plaintiff Deadline: What It Means for Shareholders

In securities class action litigation, the lead plaintiff has the authority to represent the entire class of shareholders and make key legal decisions. Faruqi & Faruqi’s notice emphasizes that investors who purchased agilon health shares during the relevant period and experienced losses have until March 2, 2026 to file a motion with the court to be considered for this role.

Whether an investor chooses to pursue lead plaintiff status or remain a member of the class without an active role, each shareholder still retains the right to potential recovery. Filing before the deadline is essential to protect these legal rights.

Who Should Contact the Law Firm?

Faruqi & Faruqi encourages not only individual and institutional investors who suffered losses, but also anyone with inside knowledge of agilon health’s conduct to come forward. This includes potential whistleblowers, former employees, business partners, shareholders, or other individuals with information that may support the legal claims.

Interested parties are invited to contact Faruqi & Faruqi directly. The firm has designated specific contacts for consultations, including its Senior Partner James (Josh) Wilson. Potential plaintiffs can inquire about their legal options and receive guidance on how best to proceed as part of the class action.

The Legal Process in Securities Class Actions

Securities class actions like the one involving agilon health typically follow a multi-stage process:

• Investigation Phase: Law firms review public disclosures, internal information, and market performance to determine whether valid legal claims exist.
• Pleadings and Filing: Once sufficient evidence is obtained, a complaint is filed in federal court outlining the alleged misconduct.
• Lead Plaintiff Appointment: Eligible class members may apply to be appointed as lead plaintiff, with courts typically choosing the one with the largest financial stake.
• Discovery and Litigation: Both sides gather evidence and prepare for potential trial unless a settlement is reached earlier.
• Resolution: Many securities lawsuits conclude with negotiated settlements providing financial compensation to class members.

How to Learn More and Take Action

Investors seeking further details can visit Faruqi & Faruqi’s official case page dedicated to agilon health, review legal documentation, or speak directly with the firm’s partners. There are also options to receive ongoing updates through Faruqi & Faruqi’s social media channels on platforms like LinkedIn, X (formerly Twitter), and Facebook.

Investor Guidance and Final Thoughts

For many investors, understanding their legal rights after a significant investment loss can be complex. The involvement of experienced securities litigators like Faruqi & Faruqi can provide clarity on available avenues for recovery. However, timing is critical: missed deadlines can hinder an investor’s ability to participate fully in litigation or to pursue meaningful compensation.

Whether through lead plaintiff status or as a class member, shareholders of agilon health, inc. are advised to assess their situation quickly and consult with legal counsel to ensure their interests are protected.

#AgilonHealth #SecuritiesClassAction #InvestorRights #FaruqiLaw #SlimScan #GrowthStocks #CANSLIM